GF Securities: give the initial rating of "buy" to Jingdong health, with the target price of HK $149.68
GF Securities said it gave Jingdong health an initial "buy" rating with a target price of HK $149.68.
This text is a result of machine translation.
Related companies：
Briefing Feb 21, 2022 10:29 AM
· Healthcare
Baidu responded that it was unable to search "referee document network": caused by misoperation of the technical team
In-depth
Briefing Nov 26, 2021 09:48 PM
· Healthcare
Baiji Shenzhou has reached strategic cooperation with JD health
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Aug 25, 2021 06:40 PM
· Healthcare
JD Health with continued good growth
Briefing Aug 24, 2021 07:43 PM
· Healthcare
Nachuan Co., Ltd. received the supervision letter: due to the lack of timely disclosure of financial assistance
In-depth
Briefing Jun 27, 2021 10:18 PM
· Healthcare
The first online and offline integrated atrial fibrillation specialist platform in China
Briefing Jun 01, 2021 12:24 AM
Jingdong health 618 pre sale report: the order volume increased 364% year on year, and the number of stomatological users increased more than 6 times
Insight
Briefing Dec 15, 2020 04:52 PM
· Healthcare
From December 22, the stock exchange of Jingdong and Hong Kong will be listed in the health adjustment mechanism.
Briefing Sep 18, 2020 12:24 PM
· Healthcare
JD Health’s New Move on Hong Kong IPO
Briefing Sep 04, 2020 12:07 PM
· Healthcare
JD Health Helps Pandemic-Center Hubei with Medical Care
Briefing Aug 17, 2020 09:44 PM
· Healthcare
Hillhouse Expects to Invest in JD Health for over USD 830 Mn
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Chinese Enterprises are Ready to Tell Stories of Green China at COP28
Dec 02, 2023 12:28 AM
Insight
In-depth